SGLT2 Mediates Glucose-Induced Angiotensinogen Synthesis in Proximal Tubule Cells

SGLT2 介导近端小管细胞中葡萄糖诱导的血管紧张素原合成

基本信息

项目摘要

 DESCRIPTION (provided by applicant): The intra-renal renin-angiotensin system (RAS) has been implicated in the development of hypertension and the progression of kidney injury that results from diabetes mellitus. RAS blockade is an effective strategy in preventing diabetic nephropathy and hypertension during diabetes. The production of angiotensinogen (AGT) is upregulated in the renal proximal tubular cells under high glucose conditions. This process is partially mediated by the formation of reactive oxygen species (ROS) as a result of glucose metabolism and mitochondrial respiration. AGT forms angiotensin II (Ang II) which causes oxidative stress by activating the Ang II Type 1 Receptor (AT1R). AT1R activation is also a major source of ROS generation in proximal tubular cells. The overall aim of this proposal is to elucidate the mechanisms underlying the up-regulation of AGT in the proximal tubule during diabetes and chronic hyperglycemia. The sodium-glucose cotransporter 2 (SGLT2) is the primary mechanism responsible for reabsorbing filtered glucose in the kidney. It is not known if SGLT2- mediated glucose reabsorption is responsible for the increased intratubular AGT expression reported during diabetes. Therefore, our overall hypothesis is that the increase in AGT expression in proximal tubular cells under high glucose conditions is mediated by increased glucose entry via SGLT2 which synergizes with the effects of AT1R activation. This will provide insight into the molecular mechanisms that occur in the kidney in the early stages of diabetes. To test this hypothesis, we will establish an increase in ROS accumulation and AGT expression in proximal tubular cells cultured in high glucose conditions and that this upregulation is dependent on glucose entry via SGLT2. We will demonstrate that glucose entry and mitochondrial respiration are increased by Ang II through AT1R activation. In addition, we will show that AT1R activation synergizes with the effects of high glucose to augment AGT expression. The experimental design will utilize immortalized proximal tubular cell lines derived from the wild type and AT1R knockout mice. Canagliflozin, a highly selective pharmaceutical blocker of SGLT2, will be used to demonstrate the role of SGLT2 on the production of AGT during high glucose conditions and address the overall hypothesis.


项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Michael Winthers Cypress其他文献

Michael Winthers Cypress的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

相似海外基金

Early endothelial function activation by angiotensin II receptor blockers prevents vascular damage in a model of diabetes
血管紧张素 II 受体阻滞剂早期激活内皮功能可预防糖尿病模型中的血管损伤
  • 批准号:
    493141
  • 财政年份:
    2023
  • 资助金额:
    $ 4.31万
  • 项目类别:
Clinical benefits and mechanism of action of angiotensin-II receptor blocker on Cardiovascular remodeling in patients with repaired coarctation of aorta
血管紧张素II受体阻滞剂对主动脉缩窄修复患者心血管重塑的临床疗效及作用机制
  • 批准号:
    10734120
  • 财政年份:
    2023
  • 资助金额:
    $ 4.31万
  • 项目类别:
Role of Angiotensin II in Bladder Dysfunction
血管紧张素 II 在膀胱功能障碍中的作用
  • 批准号:
    10707997
  • 财政年份:
    2022
  • 资助金额:
    $ 4.31万
  • 项目类别:
Regulation of nuclear calcium and ROS by Angiotensin II in heart cells. Régulation du calcium et ROS nucléaires par l'angiotensine II dans les cellules cardiaques.
血管紧张素 II 对心脏细胞中核钙和 ROS 的调节。
  • 批准号:
    RGPIN-2016-04414
  • 财政年份:
    2022
  • 资助金额:
    $ 4.31万
  • 项目类别:
    Discovery Grants Program - Individual
Role of Angiotensin II in Bladder Dysfunction
血管紧张素 II 在膀胱功能障碍中的作用
  • 批准号:
    10555926
  • 财政年份:
    2022
  • 资助金额:
    $ 4.31万
  • 项目类别:
Regulation of nuclear calcium and ROS by Angiotensin II in heart cells. Régulation du calcium et ROS nucléaires par l'angiotensine II dans les cellules cardiaques.
血管紧张素 II 对心脏细胞中核钙和 ROS 的调节。
  • 批准号:
    RGPIN-2016-04414
  • 财政年份:
    2021
  • 资助金额:
    $ 4.31万
  • 项目类别:
    Discovery Grants Program - Individual
Targeting cancer-associated fibroblasts and tumour hypoxia with angiotensin II receptor blockers
使用血管紧张素 II 受体阻滞剂靶向癌症相关成纤维细胞和肿瘤缺氧
  • 批准号:
    445961
  • 财政年份:
    2021
  • 资助金额:
    $ 4.31万
  • 项目类别:
    Operating Grants
Intratubular Angiotensin II and AT1a Receptors in The Proximal Tubules: Roles in Hypertension and Kidney Injury
近曲小管中的管内血管紧张素 II 和 AT1a 受体:在高血压和肾损伤中的作用
  • 批准号:
    10164776
  • 财政年份:
    2020
  • 资助金额:
    $ 4.31万
  • 项目类别:
Novel Roles of Mitochondrial Angiotensin II in The Proximal Tubule of The Kidney
线粒体血管紧张素 II 在肾近端小管中的新作用
  • 批准号:
    10251271
  • 财政年份:
    2020
  • 资助金额:
    $ 4.31万
  • 项目类别:
Metabolic and epigenetic regulation of cancer associated fibroblasts by angiotensin II
血管紧张素 II 对癌症相关成纤维细胞的代谢和表观遗传调控
  • 批准号:
    440714
  • 财政年份:
    2020
  • 资助金额:
    $ 4.31万
  • 项目类别:
    Fellowship Programs
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了